Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Trends in in-hospital outcome after percutaneous coronary intervention in the drug-eluting stents era.

Liu SW, Xu B, Chen J, Hu FH, Wu YJ, Li JJ, Yang YJ, Chen JL, Gao RL, Qiao SB.

Clin Cardiol. 2010 Aug;33(8):516-21. doi: 10.1002/clc.20786.

2.

Hybrid strategy of a bare metal stent combined with a drug-eluting stent versus exclusive drug-eluting stent implantation for multivessel percutaneous coronary intervention.

Syed AI, Ben-Dor I, Li Y, Collins SD, Torguson R, Wakabayashi K, Gonzalez MA, Maluenda G, Delhaye C, Belle L, Gaglia MA Jr, Xue Z, Kaneshige K, Bernardo N, Kent KM, Suddath WO, Satler LF, Pichard AD, Lindsay J, Waksman R.

EuroIntervention. 2011 Apr;6(9):1085-90. doi: 10.4244/EIJV6I9A189.

PMID:
21518681
3.

A comparative analysis of major clinical outcomes using drug-eluting stents versus bare-metal stents in a large consecutive patient cohort.

Bental T, Assali A, Vaknin-Assa H, Lev EI, Brosh D, Fuchs S, Battler A, Kornowski R.

Catheter Cardiovasc Interv. 2010 Sep 1;76(3):374-80. doi: 10.1002/ccd.22507.

PMID:
20839351
4.

Impact of smoking on the outcome of patients treated with drug-eluting stents: 1-year results from the prospective multicentre German Drug-Eluting Stent Registry (DES.DE).

Sherif MA, Nienaber CA, Toelg R, Abdel-Wahab M, Geist V, Schneider S, Senges J, Kuck KH, Tebbe U, Richardt G.

Clin Res Cardiol. 2011 May;100(5):413-23. doi: 10.1007/s00392-010-0259-y. Epub 2010 Dec 1.

PMID:
21116637
5.

Exercise stress test results in patients with bare metal stents or drug-eluting stents: pathophysiological and clinical implications.

Nerla R, Di Monaco A, Sgueglia GA, Battipaglia I, Careri G, Pinnacchio G, Tarzia P, Lanza GA, Crea F.

Circ J. 2010 Nov;74(11):2372-8. Epub 2010 Sep 4.

6.

Outcomes of diabetics receiving bare-metal stents versus drug-eluting stents.

Ramanath VS, Brown JR, Malenka DJ, DeVries JT, Sidhu MS, Robb JF, Jayne JE, Hettleman BD, Friedman BJ, Niles NW 2nd, Kaplan AV, Thompson CA; Dartmouth Dynamic Registry Investigators..

Catheter Cardiovasc Interv. 2010 Oct 1;76(4):473-81. doi: 10.1002/ccd.22512.

PMID:
20882647
7.

Appraising the impact of left ventricular ejection fraction on outcomes of percutaneous drug-eluting stenting for unprotected left main disease: insights from a multicenter registry of 975 patients.

Biondi-Zoccai G, Sheiban I, Moretti C, Palmerini T, Marzocchi A, Capodanno D, Tamburino C, Margheri M, Vecchi G, Sangiorgi G, Santarelli A, Bartorelli AL, Briguori C, Vignali L, Pede Fd, Ramondo A, Medda M, de Carlo M, Falsini G, Benassi A, Palmieri C, Filippone V, Sangiorgi D, Barlocco F, de Servi S.

Clin Res Cardiol. 2011 May;100(5):403-11. doi: 10.1007/s00392-010-0258-z. Epub 2010 Dec 3.

PMID:
21128078
8.

Relation between clopidogrel discontinuation and early cardiovascular events after percutaneous coronary intervention with drug-eluting stents.

Lemesle G, Torguson R, Bonello L, de Labriolle A, Maluenda G, Ben-Dor I, Collins SD, Syed AI, Xue Z, Satler LF, Pichard AD, Waksman R.

EuroIntervention. 2011 Apr;6(9):1053-9. doi: 10.4244/EIJV6I9A184.

PMID:
21518676
9.

Long-term outcomes after coronary bare-metal-stent and drug-eluting-stent implantations: a 'real-world' comparison among patients with diabetes with diffuse small vessel coronary artery disease.

Koh AS, Chia S, Choi LM, Sim LL, Chua TS, Koh TH, Tan JW.

Coron Artery Dis. 2011 Mar;22(1):96-9. doi: 10.1097/MCA.0b013e32834236d0.

PMID:
21164343
10.

Clinical outcome and quality of life after interventional treatment of left main disease with drug-eluting-stents in comparison to CABG in elderly and younger patients.

Rittger H, Rieber J, Kögler K, Sinha A, Schmidt M, Breithardt OA, Biggar P, Einsle F, Diegeler A, Brachmann J.

Clin Res Cardiol. 2011 May;100(5):439-46. doi: 10.1007/s00392-010-0262-3. Epub 2010 Dec 2.

PMID:
21125287
11.

Comparison of single- versus two-stent techniques in treatment of unprotected left main coronary bifurcation disease.

Kim WJ, Kim YH, Park DW, Yun SC, Lee JY, Kang SJ, Lee SW, Lee CW, Park SW, Park SJ.

Catheter Cardiovasc Interv. 2011 May 1;77(6):775-82. doi: 10.1002/ccd.22915. Epub 2011 Jan 4.

PMID:
21520380
12.

The Holy Grail for DES: does efficacy translate into real world effectiveness?

Hillegass WB.

Catheter Cardiovasc Interv. 2010 Sep 1;76(3):381-2. doi: 10.1002/ccd.22749. No abstract available.

PMID:
20839352
13.

Safety and efficacy of drug eluting stents compared with bare metal stents for saphenous vein graft interventions: a comprehensive meta-analysis of randomized trials and observational studies comprising 7,994 patients.

Hakeem A, Helmy T, Munsif S, Bhatti S, Mazraeshahi R, Cilingiroglu M, Effat M, Leesar M, Arif I.

Catheter Cardiovasc Interv. 2011 Feb 15;77(3):343-55. doi: 10.1002/ccd.22720. Epub 2010 Nov 2.

PMID:
21328679
14.
15.

Twenty-year evolution of percutaneous coronary intervention and its impact on clinical outcomes: a report from the National Heart, Lung, and Blood Institute-sponsored, multicenter 1985-1986 PTCA and 1997-2006 Dynamic Registries.

Venkitachalam L, Kip KE, Selzer F, Wilensky RL, Slater J, Mulukutla SR, Marroquin OC, Block PC, Williams DO, Kelsey SF; Investigators of NHLBI-Sponsored 1985-1986 PTCA and 1997-2006 Dynamic Registries..

Circ Cardiovasc Interv. 2009 Feb;2(1):6-13. doi: 10.1161/CIRCINTERVENTIONS.108.825323. Epub 2008 Dec 15.

16.

Impaired coronary vasomotion after coronary intervention with drug-eluting stents.

Ishihara M.

Circ J. 2010 Nov;74(11):2293-4. Epub 2010 Oct 16. No abstract available.

17.

Optimizing the impact of primary percutaneous coronary intervention in acute myocardial infarction.

Satler LF.

Catheter Cardiovasc Interv. 2011 Feb 1;77(2):201. doi: 10.1002/ccd.22952. No abstract available.

PMID:
21290554
18.

Drug eluting stents in CTOs: why not?

Vetrovec GW.

Catheter Cardiovasc Interv. 2011 Feb 15;77(3):333-4. doi: 10.1002/ccd.22976. No abstract available.

PMID:
21328678
19.

Drug-eluting stents in patients with end-stage renal disease: meta-analysis and systematic review of the literature.

Abdel-Latif A, Mukherjee D, Mesgarzadeh P, Ziada KM.

Catheter Cardiovasc Interv. 2010 Dec 1;76(7):942-8. doi: 10.1002/ccd.22562. Review.

PMID:
20506492
20.

Long-term clinical outcomes and cost-effectiveness analysis in multivessel percutaneous coronary interventions: comparison of drug-eluting stents, bare-metal stents and a mixed approach in patients at high and low risk of repeat revascularisation.

Varani E, Guastaroba P, Di Tanna GL, Saia F, Balducelli M, Campo G, Vignali L, Rossi R, Manari A, Piovaccari G, De Palma R, Marzocchi A.

EuroIntervention. 2010 Apr;5(8):953-61. doi: 10.4244/.

PMID:
20542781

Supplemental Content

Support Center